Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 10,380,493	$ 7,217,469
Restricted cash	110,000	55,000
Prepaid expenses	509,833	250,944
Research and development tax rebate receivable	518,098	358,277
Other current assets	30,942	16,344
Total current assets	11,549,366	7,898,034
Furniture and equipment, net	54,487	11,467
Intangible assets, net	99,375	75,686
Other assets	17,218	178,907
Total Assets	11,720,446	8,164,094
Current liabilities
Accounts payable	353,328	334,901
Accrued expenses	177,074	90,105
Payroll liabilities	935,070	784,867
Stock-based compensation liability	1,410,025
Other current liabilities	39,939	15,534
Total Current Liabilities	2,915,436	1,225,407
Commitments and contingencies (note 13)
Stockholders' equity
Preferred stock - $0.001 par value; 10,000,000 shares authorized, consisting of Series A convertible preferred stock- $0.001 par value; 4,000 shares authorized, and 0 shares outstanding as of December 31, 2018 and December 31, 2017; Series B convertible preferred stock- $0.001 par value; 25,000 and 0 shares authorized, and 2,379 and 0 shares issued and outstanding as of December 31, 2018 and December 31, 2017, respectively	2
Additional paid-in capital- Series B convertible preferred stock	2,378,997
Common stock - $0.18 par value; 175,000,000 shares authorized, and 5,846,552 and 2,651,952 shares issued and outstanding, as of December 31, 2018 and December 31, 2017, respectively	1,052,372	477,342
Additional paid-in capital	82,204,902	71,887,674
Accumulated deficit	(76,831,263)	(65,426,329)
Total Stockholders' Equity	8,805,010	6,938,687
Total Liabilities and Stockholders' Equity	$ 11,720,446	$ 8,164,094